Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 2 6Phase NA 3Phase 1 2Phase 4 1Phase 2/3 1

Status

Terminated 1

Sponsor Class

INDUSTRY 5OTHER 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pleural Effusion, Malignant 1Ovarian Cysts 1Mycosis Fungoides 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Long Qt Syndrome 3 1Localized Advanced Rectal Adenocarcinoma 1Leukemia, Myeloid, Acute 1Kidney Neoplasms 1Infertility 1Hodgkin Disease 1Endometriosis 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Methotrexate 1Introns 1Interferon alpha-2 1Clorazepate Dipotassium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × NETWORK × Lymphoma, T-Cell, Cutaneous × Clear all
NCT02323659 2022-01-13

Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas

Polish Lymphoma Research Group

Phase 4 Terminated
100 enrolled
DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡